Comprehensive approach to managing hidradenitis suppurativa patients

Int J Dermatol. 2020 Jun;59(6):744-747. doi: 10.1111/ijd.14870. Epub 2020 Apr 6.

Authors

Erin K Collier¹, Jennifer L Hsiao², Vivian Y Shi³, Haley B Naik⁴

Affiliations

¹ David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
² Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
³ Division of Dermatology, Department of Medicine, University of Arizona, Tucson, AZ, USA.
⁴ Department of Dermatology, University of California, San Francisco, CA, USA.

No abstract available

MeSH terms

Academic Medical Centers / organization & administration
Clinical Trials as Topic
Comorbidity
Delayed Diagnosis / prevention & control
Dermatologists / education
Dermatologists / organization & administration
Dermatology / education
Dermatology / methods
Dermatology / organization & administration*
Evidence-Based Medicine / education
Evidence-Based Medicine / methods
Evidence-Based Medicine / organization & administration*
Hidradenitis Suppurativa / diagnosis
Hidradenitis Suppurativa / epidemiology
Hidradenitis Suppurativa / psychology
Hidradenitis Suppurativa / therapy*
Humans
Internship and Residency / organization & administration
Intersectoral Collaboration
Mental Health
Patient Participation
Prevalence
Psychiatry / methods
Psychiatry / organization & administration
Quality of Life
Specialties, Surgical / methods
Specialties, Surgical / organization & administration
Treatment Outcome
United States / epidemiology

Grants and funding

K23 AR074531/AR/NIAMS NIH HHS/United States